These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7557889)

  • 1. p53 proteins and aflatoxin b1: the good, the bad, and the ugly.
    Liang TJ
    Hepatology; 1995 Oct; 22(4 Pt 1):1330-2. PubMed ID: 7557889
    [No Abstract]   [Full Text] [Related]  

  • 2. p53 mutations in nonmalignant human liver: fingerprints of aflatoxins?
    Ozturk M
    Hepatology; 1995 Feb; 21(2):600-1. PubMed ID: 7843737
    [No Abstract]   [Full Text] [Related]  

  • 3. Epidemiology of human aflatoxin exposures and their relationship to liver cancer.
    Groopman JD; Scholl P; Wang JS
    Prog Clin Biol Res; 1996; 395():211-22. PubMed ID: 8895991
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma.
    Yakicier MC; Legoix P; Vaury C; Gressin L; Tubacher E; Capron F; Bayer J; Degott C; Balabaud C; Zucman-Rossi J
    Oncogene; 2001 Aug; 20(37):5232-8. PubMed ID: 11526514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aflatoxin and p53 abnormality in duck hepatocellular carcinoma.
    Imazeki F; Yokosuka O; Ohto M; Omata M
    J Gastroenterol Hepatol; 1995; 10(6):646-9. PubMed ID: 8580407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chemistry and biology of aflatoxin B(1): from mutational spectrometry to carcinogenesis.
    Smela ME; Currier SS; Bailey EA; Essigmann JM
    Carcinogenesis; 2001 Apr; 22(4):535-45. PubMed ID: 11285186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma p53 G > T transversions at codon 249: the fingerprint of aflatoxin exposure?
    Lasky T; Magder L
    Environ Health Perspect; 1997 Apr; 105(4):392-7. PubMed ID: 9189703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographic variation of p53 mutational profile in nonmalignant human liver.
    Aguilar F; Harris CC; Sun T; Hollstein M; Cerutti P
    Science; 1994 May; 264(5163):1317-9. PubMed ID: 8191284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different frequencies of p53 codon-249 hot-spot mutations in hepatocellular carcinomas in Jiang-su province of China.
    Shimizu Y; Zhu JJ; Han F; Ishikawa T; Oda H
    Int J Cancer; 1999 Jul; 82(2):187-90. PubMed ID: 10389750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relationship to aflatoxin B1-DNA adducts and p53 mutation in hepatocellular carcinoma.
    Zhang YJ; Chen Y; Ahsan H; Lunn RM; Lee PH; Chen CJ; Santella RM
    Int J Cancer; 2003 Feb; 103(4):440-4. PubMed ID: 12478658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
    Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ
    Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis.
    Shen HM; Ong CN
    Mutat Res; 1996 Oct; 366(1):23-44. PubMed ID: 8921985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of mutations in the p53 tumor suppressor gene in woodchuck hepatocellular carcinomas associated with hepadnavirus infection and intake of aflatoxin B1.
    Rivkina M; Cote PJ; Robinson WS; Tennant BC; Marion PL
    Carcinogenesis; 1996 Dec; 17(12):2689-94. PubMed ID: 9006107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of aflatoxin, mutant P53 gene and sIL-2 receptor in liver cirrhosis and hepatocellular carcinoma.
    El-Shanawani FM; Abdel-Hadi AA; Abu Zikri NB; Ismail A; El-Ansary M; El-Raai A
    J Egypt Soc Parasitol; 2006 Apr; 36(1):221-39. PubMed ID: 16605112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aflatoxins as a cause of hepatocellular carcinoma.
    Kew MC
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):305-10. PubMed ID: 24078988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aflatoxin and hepatocellular carcinoma: a useful paradigm for environmentally induced carcinogenesis.
    Kolars JC
    Hepatology; 1992 Sep; 16(3):848-51. PubMed ID: 1324219
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence that mutational activation of the ras genes may not be involved in aflatoxin B(1)-induced human hepatocarcinogenesis, based on sequence analysis of the ras and p53 genes.
    Chao HK; Tsai TF; Lin CS; Su TS
    Mol Carcinog; 1999 Oct; 26(2):69-73. PubMed ID: 10506750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico.
    Soini Y; Chia SC; Bennett WP; Groopman JD; Wang JS; DeBenedetti VM; Cawley H; Welsh JA; Hansen C; Bergasa NV; Jones EA; DiBisceglie AM; Trivers GE; Sandoval CA; Calderon IE; Munoz Espinosa LE; Harris CC
    Carcinogenesis; 1996 May; 17(5):1007-12. PubMed ID: 8640905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxin B1.
    Park US; Su JJ; Ban KC; Qin L; Lee EH; Lee YI
    Gene; 2000 Jun; 251(1):73-80. PubMed ID: 10863098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene.
    Cerutti P; Hussain P; Pourzand C; Aguilar F
    Cancer Res; 1994 Apr; 54(7 Suppl):1934s-1938s. PubMed ID: 7907948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.